Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB023 in Lupus Nephritis
NCT01499355Phase 2Terminated
- Sponsor
- Biogen
- Start
- Jul 2012
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 21
01
Overview
A Phase 2 trial of voralizumab in lupus nephritis (LN), sponsored by Biogen. Started Jul 2012; status: terminated.
02
Drugs
voralizumab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01499355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499355.